1. Home
  2. ACOG vs OCAC Comparison

ACOG vs OCAC Comparison

Compare ACOG & OCAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$9.10

Market Cap

193.6M

Sector

N/A

ML Signal

N/A

Logo Ocean Capital Acquisition Corporation Ordinary Shares

OCAC

Ocean Capital Acquisition Corporation Ordinary Shares

N/A

Current Price

$9.99

Market Cap

156.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ACOG
OCAC
Founded
2000
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
156.2M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
ACOG
OCAC
Price
$9.10
$9.99
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $18.00
N/A
AVG Volume (30 Days)
★ 98.1K
45.0K
Earning Date
11-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 41.58
N/A
EPS
N/A
★ N/A
Revenue
★ $10,220,275.00
N/A
Revenue This Year
$153.87
N/A
Revenue Next Year
$85.66
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$9.86
52 Week High
$10.14
$10.05

Technical Indicators

Market Signals
Indicator
ACOG
OCAC
Relative Strength Index (RSI) 50.32 71.41
Support Level $7.50 $9.94
Resistance Level $9.17 N/A
Average True Range (ATR) 0.48 0.02
MACD 0.03 0.00
Stochastic Oscillator 55.75 45.45

Price Performance

Historical Comparison
ACOG
OCAC

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About OCAC Ocean Capital Acquisition Corporation Ordinary Shares

Ocean Capital Acquisition Corp is a blank check company.

Share on Social Networks: